Laboratory and field evaluations of novaluron, a new insect growth regulator (IGR), against Culex mosquitoes.
Limited laboratory and field studies have indicated that the insect growth regulator (IGR) novaluron exhibits good activity against larvae of pest species in the orders Coleoptera, Hemiptera (suborder Heteroptera), and Lepidoptera by both ingestion and contact. We completed laboratory and field studies to evaluate activity and efficacy of novaluron against Culex mosquitoes. In laboratory studies, novaluron was highly active against Cx. quinquefasciatus, as indicated by low levels of inhibition of emergency (IE), at the 50% level, IE50 (0.159 ppb for 2nd-stage larvae and 0.118 ppb for 4th-stage larvae) and IE90, at the 90% level, (0.604 ppb for 2nd-stage larvae and 0.595 ppb for 4th-stage larvae). In outdoor microcosm and mesocosm studies against natural populations, novaluron yielded excellent control of immature Culex mosquitoes for up to 14 days at 1.25, 2.5, and 5 ppb in microcosms, and for up to 7 days at the dosages of 1, 5, and 10 mg/m2 in mesocosms. Based on qualitative observations, novaluron seemed to have a favorable margin of safety for nontarget aquatic invertebrates cohabiting with mosquito larvae. Further large-scale field studies are warranted to evaluate initial efficacy and longevity of novaluron against various mosquito species, as well as its safety for nontarget biota.